NO20004026L - FremgangsmÕter og mellomprodukter som er nyttige for Õ danne antifolater - Google Patents

FremgangsmÕter og mellomprodukter som er nyttige for Õ danne antifolater

Info

Publication number
NO20004026L
NO20004026L NO20004026A NO20004026A NO20004026L NO 20004026 L NO20004026 L NO 20004026L NO 20004026 A NO20004026 A NO 20004026A NO 20004026 A NO20004026 A NO 20004026A NO 20004026 L NO20004026 L NO 20004026L
Authority
NO
Norway
Prior art keywords
methods
antifolates
forming
intermediates useful
intermediates
Prior art date
Application number
NO20004026A
Other languages
English (en)
Other versions
NO20004026D0 (no
Inventor
Charles Jackson Barnett
Steven Eugene Dunlap
Michael Edward Kobierski
John Arnold Werner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20004026D0 publication Critical patent/NO20004026D0/no
Publication of NO20004026L publication Critical patent/NO20004026L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Foreliggende oppfinnelse vedrører mellomprodukter, og fremgangsmåter rettet på og fra disse mellomproduktene, på en serie av pyrimidin derivater med formel (V), som er mellomprodukter for nyttige antifolat forbindelser eller som selv er nyttige antifolat forbindelser.
NO20004026A 1998-02-11 2000-08-10 FremgangsmÕter og mellomprodukter som er nyttige for Õ danne antifolater NO20004026L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7432798P 1998-02-11 1998-02-11
PCT/US1999/001689 WO1999041230A1 (en) 1998-02-11 1999-01-27 Processes and intermediates useful to make antifolates

Publications (2)

Publication Number Publication Date
NO20004026D0 NO20004026D0 (no) 2000-08-10
NO20004026L true NO20004026L (no) 2000-10-04

Family

ID=22118973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004026A NO20004026L (no) 1998-02-11 2000-08-10 FremgangsmÕter og mellomprodukter som er nyttige for Õ danne antifolater

Country Status (18)

Country Link
US (1) US6426417B1 (no)
EP (1) EP1054859A4 (no)
JP (1) JP2002503648A (no)
KR (1) KR20010040836A (no)
CN (1) CN1290247A (no)
AR (1) AR018538A1 (no)
AU (1) AU739292B2 (no)
BR (1) BR9907876A (no)
CA (1) CA2319424A1 (no)
EA (1) EA002723B1 (no)
HR (1) HRP20000537A2 (no)
HU (1) HUP0100869A3 (no)
IL (1) IL137685A0 (no)
NO (1) NO20004026L (no)
NZ (1) NZ505406A (no)
PL (1) PL342161A1 (no)
TR (1) TR200002352T2 (no)
WO (1) WO1999041230A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2391153T3 (es) 2000-02-28 2012-11-22 Novartis Vaccines And Diagnostics S.R.L. Expresión heteróloga de proteínas de Neisseria
KR101686179B1 (ko) 2015-02-05 2016-12-28 이삼구 산화질소를 생성하는 아르기닌 함유가 증진된 귀뚜라미

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51113874A (en) 1975-04-01 1976-10-07 Yamanouchi Pharmaceut Co Ltd Method for synthesizing 4-hydroxynicotinic acid or its lower alkyl est ers
JPS55730A (en) 1978-06-20 1980-01-07 Toyo Soda Mfg Co Ltd 5-h-pyrido 1',2':1,2-pyrimido 4, 5-b acridine 7, 15-dione and its preparation
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
NZ219971A (en) * 1986-06-06 1989-08-29 Univ Princeton Tetrahydropyrido (2,3-d pyrimidine derivatives and pharmaceutical compositions
US4895946A (en) * 1987-10-26 1990-01-23 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
DK172753B1 (da) * 1988-05-25 1999-06-28 Lilly Co Eli N-(5,6,7,8-tetrahydropyrido[2,3--d]pyrimidin-6-yl-alkanoyl)-glutaminsyrederivater, deres anvendelse, farmaceutiske præparat
US5248775A (en) 1989-12-11 1993-09-28 The Trustees Of Princeton University Pyrrolo(2,3-d)pyrimidines
KR0162654B1 (ko) 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
US5028608A (en) 1989-12-11 1991-07-02 The Trustees Of Princeton University N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
US5536724A (en) * 1992-03-03 1996-07-16 Sri International Antiinflammatory and antineoplastic 5-deazaaminopterins and 5,10-dideazaaminopterins

Also Published As

Publication number Publication date
HRP20000537A2 (en) 2000-10-31
TR200002352T2 (tr) 2000-12-21
EA200000829A1 (ru) 2001-02-26
EA002723B1 (ru) 2002-08-29
AU739292B2 (en) 2001-10-11
WO1999041230A1 (en) 1999-08-19
NZ505406A (en) 2003-01-31
NO20004026D0 (no) 2000-08-10
EP1054859A4 (en) 2003-03-05
CN1290247A (zh) 2001-04-04
HUP0100869A2 (hu) 2001-08-28
AU2345299A (en) 1999-08-30
EP1054859A1 (en) 2000-11-29
IL137685A0 (en) 2001-10-31
PL342161A1 (en) 2001-05-21
HUP0100869A3 (en) 2002-12-28
KR20010040836A (ko) 2001-05-15
AR018538A1 (es) 2001-11-28
JP2002503648A (ja) 2002-02-05
BR9907876A (pt) 2000-10-31
US6426417B1 (en) 2002-07-30
CA2319424A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
EA200500721A1 (ru) Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств
NO20032831L (no) Pyrimidinaminer som angiogenese-modulatorer
BR9915938A (pt) Derivados de pirimidina substituìdos por arila e heterociclila como anticoagulantes
CY1105553T1 (el) Υποκαταστατα 2-πυριμιδινυλιο-6,7,8,9-τετραϋδροπυριμιδο[1,2-α]πυριμιδιν-4-ονιο και 7-πυριμιδινυλιο-2,3-διυδροιμιδαζο[1,2-α]πυριμιδιν-5(1η)ονιο για νευροεκφυλιστικες διαταραχες
DK0539086T3 (da) Kondenserede pyrimidinderivater og deres anvendelse som angiotensin II-antagonister
DK1686119T3 (da) Pyrimidin-5-on-derivater som LDL-PLA2 inhibitorer
MXPA05011643A (es) 5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension.
IL160915A0 (en) Indolizines inhibiting kinase proteins
DK0922045T3 (da) Bicykliske pyrimidinderivater og deres anvendelse som antikoagulanter
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DE60336735D1 (de) Neue biologischaktive molekü le
DK0971922T3 (da) Tetrahydropyrido-forbindelser
DE69725440D1 (de) 2-substituierte nukleosid- und oligonukleotid- derivate
WO2003002580A8 (en) 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
NO20004026L (no) FremgangsmÕter og mellomprodukter som er nyttige for Õ danne antifolater
BR0207102A (pt) Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença
SE9604582D0 (sv) Novel compounds
EP1613606A4 (en) PROCESS FOR PREPARING 2,3,5,6-SUBSTITUTED 3H-PYRIMIDIN-4-ONES
DE50001717D1 (en) Herbizide substituierte thienocycloalk(en)ylamino-1,3,5-triazine
BR0313302A (pt) Processos para a preparação de nucleosìdeos de 1,3-dioxolano
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
UA80871C2 (en) 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
SE9603726D0 (sv) Novel compounds
ES2182541T3 (es) Pyrazolo(3,4-d)pirimidinas con actividad anticonvulsiva y antialergica /aniasmatica.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application